MedTrace Logo

Evaluation of Soy Isoflavones on Skin Ageing Parameters

NCT06047145 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-04-10

No results posted yet for this study

Summary

This double-blind, placebo-controlled, randomised pilot trial aims to assess the effect of oral soy isoflavone consumption on skin ageing parameters in post-menopausal women.

Conditions

  • Skin Ageing

Interventions

DIETARY_SUPPLEMENT

soy isoflavones

1 capsule daily for 84 days

DIETARY_SUPPLEMENT

Placebo

1 capsule daily for 84 days

Sponsors & Collaborators

  • Eurofins Dermscan Pharmascan

    collaborator INDUSTRY

  • The Archer-Daniels-Midland Company

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-27
Primary Completion
2024-02-26
Completion
2024-02-26

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06047145 on ClinicalTrials.gov